Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterising Risk and Biology Of Smouldering Myeloma for Early Detection Of Symptomatic Myeloma

NCT05047107 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT05047107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05047107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterising Risk and Biology Of Smouldering Myeloma for Early Detection Of Symptomatic Myeloma
Lead sponsor
University College, London
Phase
Observational
Overall status
Unknown status
Start date
April 15, 2021
Completion date
March 31, 2025
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mgus, multiple myeloma, smouldering myeloma